Yahoo News – Features Julia Nordgren, MED ’99, who maintains a personal health and diet practice, consults with companies on how to keep employees healthy, and offers cooking classes in order to transform the way the medical field approaches healthy eating with patients, and educate people on how diet affects health.
In the News
Your New Liver Is Only a Learjet Away: First of Three Parts
Forbes – David Axelrod, assistant professor of surgery and of community and family medicine, who conducts research on transplant allocation, comments that a medical program’s ability to move through its transplant list is more important than the size of its list.
How Good Is Your Doctor?
The Hill – In this opinion piece for The Hill, Scott Wallace, visiting professor of community and family medicine, argues that patients should be able to obtain outcome data for every condition a doctor treats. “Outcome data allows consumers to find the best services and prompts underperformers to improve,” Wallace writes.
Dartmouth Named Health Care National Center of Excellence
Boston Globe via Associated Press – Continued coverage on the $17.5 million awarded to Dartmouth from the Agency for Healthcare Research and Quality to study how well, and how quickly, hospitals learn from their successes. Quotes Elliott Fisher, director and professor of the Dartmouth Institute for Health Policy and Clinical Practice at Geisel, who will lead the work of nine researchers from Geisel joined by others from Harvard University, the University of California at Berkeley, Intermountain Health Care in Salt Lake City and the Mayo Clinic in Rochester, Minn.
Experimental Drugs May Stop Migraines Before They Start
CBS News – Continued coverage on recent research that shows a new class of drugs may prevent chronic migraines. The article quotes Thomas Ward, professor of neurology, on the recent findings. “It’s very exciting, because this would be a form of prevention that might not have a lot of side effects and would be highly effective for people who have not had good treatment,” says Ward.
Connections: Healthy Friday – Overtesting; Men’s Health, Implanted Heart Devices (Audio)
WXXI News – H. Gilbert Welch, professor of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice at Geisel, is a guest on “Healthy Friday First,” where he discusses over-testing and overtreatment in modern medicine.
3 North Texas Hospitals Inflate Bills of the Uninsured, National Study Finds
Dallas Morning News – Quotes Jonathan Skinner, professor of community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice at Geisel, and professor of economics at Dartmouth, on a recent study that revealed it is common practice at Texas General and two other for-profit medical centers in North Texas to charge patients upward of nine times the cost of care. While insurance companies and federal health care programs arrange lower prices with hospitals, the uninsured don’t have the same negotiating power and are often left with hefty bills.
Pioneer ACOs: Anatomy Of A ‘Victory’
Health Affairs Blog – References a policy objective for ACOs proposed in Health Affairs in 2007 by Elliott Fisher, director and professor of the Dartmouth Institute for Health Policy and Clinical Practice, and professor of medicine, and community and family medicine, and colleagues from Dartmouth. The policy objective focused on reducing variation in Medicare shared savings rather than containing costs.
Optical Method Maps Brain Tumor Borders
Chemical & Engineering News – References comments made by David Roberts, professor of surgery and neurology, on a new optical coherence tomography (OCT) device that surgeons could potentially use to help remove tumors from the brain.
New Drugs Might Prevent Migraines Before They Start
U.S. News & World Report via Health Day News – Quotes Thomas Ward, professor of neurology, on recent research that is closing in on a new class of drugs that can prevent chronic migraines by interrupting the chain of events thought to create the headaches. “It’s very exciting, because this would be a form of prevention that might not have a lot of side effects and would be highly effective for people who have not had good treatment,” says Ward. “The hope is these drugs will be clean, reduce the number of headaches people get, and won’t carry a lot of baggage.”